NFKB1 and neoplasm: The enriched NF-κB and MAPK pathways, along with its association with T and B cells, suggest that BCL10 may exert its effects by inducing an inflammatory response enhancing killing and inhibiting tumor cell proliferation, further emphasizing its potential significance.